Effects of Physical Training Following Selective Dorsal Rhizotomy on Non-ambulant Children With Bilateral Spastic Cerebral Palsy

April 23, 2026 updated by: Amira Mahmoud Abd-elmonem, Cairo University

Effects of Physical Training Following Selective Dorsal Rhizotomy on Trunk Control, Selectivity and Upper Extremity Function of Non-ambulant Children With Bilateral Spastic Cerebral Palsy: A Randomized Controlled Trial

Children with spastic bilateral cerebral palsy are late developers. delayed gross and fine motor development require early intervention to improve the child performance and avoid secondary impairments.

Study Overview

Detailed Description

increased tone of lower extremity muscles interfere with the child sitting posture and trunk control. delayed sitting and lack of trunk control contribute to the impairments of upper extremity functions.

selective dorsal rhizotomy is a surgical procedure to control increased tone of the lower extremities. Therefore, the current study is carried out to investigate the effects of selective dorsal rhizotomy on trunk control, selectivity and upper extremity function of non-ambulant children with bilateral spastic cerebral palsy

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Giza, Egypt, 12662
        • Amira Mahmoud Abd-elmonem

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 7 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • CP, spastic diplegia
  • 4-7 years of age
  • On Level IV-V on Gross Motor Function Classification System
  • Partial trunk control (sitting with support).

Exclusion Criteria:

  • Structural non-reducible deformities or musculoskeletal surgery in the lower extremities in the past 12 months
  • Ankle clonus
  • Exaggerated deep tendon reflex in the legs
  • Babinski sign;
  • Moderate to severe signs of dystonia, athetosis or ataxia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: control group
  • Sequenced trunk co-activation exercises
  • Righting and protective reactions
  • Functional stretching exercises.
A custom-made articulating ankle foot orthosis
Experimental: SDR-group
selective dorsal rhizotomy
  • Sequenced trunk co-activation exercises
  • Righting and protective reactions
  • Functional stretching exercises.
A custom-made articulating ankle foot orthosis
All SDRs were performed by a single neurosurgeon through an osteoplastic laminotomy from L2 to L5

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Segmental trunk control
Time Frame: period of the treatment was 4 successive months
The Segmental Assessment of Trunk Control is applied to assess upright trunk postural control in sitting position based on subdividing the trunk into 6 segments. The head/trunk control is acquired segment by segment if upright sitting posture can be maintained under three conditions including: static control at static position, active control while the child moves the head and/or arm and reactive control after external perturbation.The trunk segments according to the scale include: head/neck, thoracic (upper, mid and lower) and lumbar (upper and lower) segments. It is an ordinal scale with a grade 1 to 7 is assigned for each segment with the score 7 indicates that the infant can't retain independent sitting (no hand support). A score of 8 is given as full trunk control is gained.
period of the treatment was 4 successive months
Gross motor function
Time Frame: period of the treatment was 4 successive months
The gross motor function measure-88 is a valid and reliable criterion referenced instrument; is currently used to evaluate the motor function over time in individuals with cerebral palsy.
period of the treatment was 4 successive months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
upper extremity function
Time Frame: period of the treatment was 4 successive months
The quality of upper extremity skill test is a reliable and valid tool used to measure the motor function in children with cerebral palsy ages of 18 months to 8 years. T
period of the treatment was 4 successive months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Hazem A Aly, Phd, PhD of physical therapy for pediatrics, faculty of physical therapyCairo university
  • Study Director: Ahmed rabie, Phd, Department of neurosurgery, faculty of medicine , Alexandria university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 10, 2022

Primary Completion (Actual)

January 30, 2024

Study Completion (Actual)

December 24, 2025

Study Registration Dates

First Submitted

August 7, 2021

First Submitted That Met QC Criteria

August 7, 2021

First Posted (Actual)

August 16, 2021

Study Record Updates

Last Update Posted (Actual)

April 28, 2026

Last Update Submitted That Met QC Criteria

April 23, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bilateral Cerebral Palsy

Clinical Trials on physical therapy excercises

Subscribe